Interest Paid, Excluding Capitalized Interest, Operating Activities of LIFECORE BIOMEDICAL, INC. \DE\ from 30 May 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 30 May 2010 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Sep 2025 was $265,000, a 58% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $1,907,000, a 30% decline from 2023.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $2,730,000, a 91% decline from 2022.
  • LIFECORE BIOMEDICAL, INC. \DE\ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $31,024,000, a 84% increase from 2021.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $265,000 -$363,000 -58% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q3 2024 $628,000 27 May 2024 25 Aug 2024 10-Q 06 Nov 2025 2026 Q1

LIFECORE BIOMEDICAL, INC. \DE\ Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,907,000 -$823,000 -30% 27 May 2024 25 May 2025 10-K 07 Aug 2025 2025 FY
2023 $2,730,000 -$28,294,000 -91% 29 May 2023 26 May 2024 10-K 07 Aug 2025 2025 FY
2022 $31,024,000 +$14,136,000 +84% 30 May 2022 28 May 2023 10-K 26 Aug 2024 2024 FY
2021 $16,888,000 +$3,665,000 +28% 31 May 2021 29 May 2022 10-K 26 Aug 2024 2024 FY
2020 $13,223,000 +$3,093,000 +31% 01 Jun 2020 30 May 2021 10-K 20 Mar 2024 2023 FY
2019 $10,130,000 +$4,516,000 +80% 27 May 2019 31 May 2020 10-K/A 16 Mar 2023 2022 FY
2018 $5,614,000 +$3,322,000 +145% 28 May 2018 26 May 2019 10-K 29 Jul 2021 2021 FY
2017 $2,292,000 -$40,000 -1.7% 29 May 2017 27 May 2018 10-K 14 Aug 2020 2020 FY
2016 $2,332,000 +$315,000 +16% 30 May 2016 28 May 2017 10-K 01 Aug 2019 2019 FY
2015 $2,017,000 01 Jun 2015 29 May 2016 10-K 09 Aug 2018 2018 FY
2011 $952,000 +$191,000 +25% 30 May 2011 27 May 2012 10-K 08 Aug 2012 2012 FY
2010 $761,000 +$673,000 +765% 31 May 2010 29 May 2011 10-K 08 Aug 2012 2012 FY
2009 $88,000 01 Jun 2009 30 May 2010 10-K 08 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.